FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.13 | FHIR Version n/a User: [n/a]

13429511000001107: Ibuprofen 10% gel (Vantage) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Ibuprofen 10% gel (Vantage)
\UK product\Virtual medicinal product\Product containing precisely ibuprofen 100 milligram/1 gram conventional release cutaneous gel\Ibuprofen 10% gel (Vantage)
\UK product\Virtual therapeutic moiety\Ibuprofen\Product containing only ibuprofen in cutaneous dose form (medicinal product form)\Product containing precisely ibuprofen 100 milligram/1 gram conventional release cutaneous gel\Ibuprofen 10% gel (Vantage)
\UK product\Virtual therapeutic moiety\Ibuprofen\Product containing precisely ibuprofen 100 milligram/1 gram conventional release cutaneous gel\Ibuprofen 10% gel (Vantage)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

47338301000001111 Ibuprofen 10% gel (Vantage) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

47338401000001115 Ibuprofen 10% gel (Vantage) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ibuprofen 10% gel (Vantage)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Is a	Product containing precisely ibuprofen 100 milligram/1 gram conventional release cutaneous gel	true	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Has active ingredient	Ibuprofen	false	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Has manufactured dose form	Gel	false	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Has manufactured dose form	Cutaneous AND/OR transdermal dosage form	false	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Has specific active ingredient	Ibuprofen	true	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Has dispensed dose form	Gel	true	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ibuprofen 10% gel (Vantage) 50 gram	Is pack of	False	Ibuprofen 10% gel (Vantage)	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Vantage) 50 gram	Has AMP	True	Ibuprofen 10% gel (Vantage)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
47338301000001111	Ibuprofen 10% gel (Vantage) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
47338401000001115	Ibuprofen 10% gel (Vantage)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module